The Biden administration’s extension of the COVID-19 emergency declaration until 2029 raises critical questions about accountability and the influence of pharmaceutical companies. Discover the implications of this controversial decision and the concerns it has sparked among critics.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed